» Articles » PMID: 29946067

Hypokalaemic Periodic Paralysis and Myotonia in a Patient with Homozygous Mutation P.R1451L in Na1.4

Overview
Journal Sci Rep
Specialty Science
Date 2018 Jun 28
PMID 29946067
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Dominantly inherited channelopathies of the skeletal muscle voltage-gated sodium channel Na1.4 include hypokalaemic and hyperkalaemic periodic paralysis (hypoPP and hyperPP) and myotonia. HyperPP and myotonia are caused by Na1.4 channel overactivity and overlap clinically. Instead, hypoPP is caused by gating pore currents through the voltage sensing domains (VSDs) of Na1.4 and seldom co-exists clinically with myotonia. Recessive loss-of-function Na1.4 mutations have been described in congenital myopathy and myasthenic syndromes. We report two families with the Na1.4 mutation p.R1451L, located in VSD-IV. Heterozygous carriers in both families manifest with myotonia and/or hyperPP. In contrast, a homozygous case presents with both hypoPP and myotonia, but unlike carriers of recessive Na1.4 mutations does not manifest symptoms of myopathy or myasthenia. Functional analysis revealed reduced current density and enhanced closed state inactivation of the mutant channel, but no evidence for gating pore currents. The rate of recovery from inactivation was hastened, explaining the myotonia in p.R1451L carriers and the absence of myasthenic presentations in the homozygous proband. Our data suggest that recessive loss-of-function Na1.4 variants can present with hypoPP without congenital myopathy or myasthenia and that myotonia can present even in carriers of homozygous Na1.4 loss-of-function mutations.

Citing Articles

Periodic paralysis.

Cannon S Handb Clin Neurol. 2024; 203:39-58.

PMID: 39174253 PMC: 11556526. DOI: 10.1016/B978-0-323-90820-7.00002-1.


Hyperkalemic Periodic Paralysis in Twenty-Two Family Members Over Four Generations: A Rare Case Report.

Vivek A, Sengar P, Chaurasia R, Pathak A, Kumar A, Singh V Ann Indian Acad Neurol. 2023; 26(4):595-597.

PMID: 37970276 PMC: 10645229. DOI: 10.4103/aian.aian_425_23.


New Challenges Resulting From the Loss of Function of Na1.4 in Neuromuscular Diseases.

Nicole S, Lory P Front Pharmacol. 2021; 12:751095.

PMID: 34671263 PMC: 8521073. DOI: 10.3389/fphar.2021.751095.


Ion Channel Gene Mutations Causing Skeletal Muscle Disorders: Pathomechanisms and Opportunities for Therapy.

Maggi L, Bonanno S, Altamura C, Desaphy J Cells. 2021; 10(6).

PMID: 34208776 PMC: 8234207. DOI: 10.3390/cells10061521.


Inherited Neuromuscular Disorders: Which Role for Serum Biomarkers?.

Lupica A, Di Stefano V, Gagliardo A, Iacono S, Pignolo A, Ferlisi S Brain Sci. 2021; 11(3).

PMID: 33801069 PMC: 8004068. DOI: 10.3390/brainsci11030398.


References
1.
Miller T, Dias da Silva M, Miller H, Kwiecinski H, Mendell J, Tawil R . Correlating phenotype and genotype in the periodic paralyses. Neurology. 2004; 63(9):1647-55. DOI: 10.1212/01.wnl.0000143383.91137.00. View

2.
Jurkat-Rott K, Groome J, Lehmann-Horn F . Pathophysiological role of omega pore current in channelopathies. Front Pharmacol. 2012; 3:112. PMC: 3372090. DOI: 10.3389/fphar.2012.00112. View

3.
Sugiura Y, Aoki T, Sugiyama Y, Hida C, Ogata M, Yamamoto T . Temperature-sensitive sodium channelopathy with heat-induced myotonia and cold-induced paralysis. Neurology. 2000; 54(11):2179-81. DOI: 10.1212/wnl.54.11.2179. View

4.
Bendahhou S, Cummins T, Kwiecinski H, Waxman S, Ptacek L . Characterization of a new sodium channel mutation at arginine 1448 associated with moderate Paramyotonia congenita in humans. J Physiol. 1999; 518 ( Pt 2):337-44. PMC: 2269438. DOI: 10.1111/j.1469-7793.1999.0337p.x. View

5.
Sokolov S, Scheuer T, Catterall W . Gating pore current in an inherited ion channelopathy. Nature. 2007; 446(7131):76-8. DOI: 10.1038/nature05598. View